Aptamers are short single-stranded DNA or RNA, which can be selected from a random combinatorial library by the systematic evolution of ligands by exponential enrichment (SELEX) in vitro. In order to obtain novel selective light-up ligands for berberine, we selected DNA aptamers for berberine by a modified affinity chromatography-based SELEX. The ssDNA library was coupled on streptavidin-coated agarose beads through the hybridization with a biotin labeled complementary oligonucleotide capture strand, and the aptamer sequences were released from agarose beads through berberine binding. This method to isolate the aptamers was simple, straightforward and effective, and three aptamers with low micromolar dissociation constants (K(d)s) were achi...
In this study, we developed a systematic evolution of ligands by exponential enrichment (SELEX) meth...
Aptamers are functional nucleic acid (FNA) species capable of specifically binding a target ligand w...
ABSTRACT: To address limitations in the production of DNA aptamers against small molecules, we intro...
Aptamers are synthetic single-stranded DNA or RNA sequences that can fold into tertiary structures a...
Aptamers are short sequences of single-stranded DNA or RNA that are able to specifically bind variou...
ABSTRACT: Aptamers are agents able to bind tightly and selectively to disease markers, offering grea...
Low-Cost diagnostic and screening tools are of vital importance for low resources countries like tho...
Aptamers are becoming a viable alternative to antibodies as bio-recognition elements in analytical, ...
Molecular recognition of disease biomarkers is essential for the detection, monitoring, and treatmen...
We describe an innovative selection approach to generate self-reporting aptamers (SRAs) capable of c...
Aptamers are an emerging class of molecules that are valued for their ability to bind with high affi...
We describe a multiple combined strategy to discover novel aptamers specific for clenbuterol (CBL). ...
We have applied SELEX (Systematic Evolution of Ligands by EXponential enrichment), a combinatorial m...
Small organic molecules are challenging targets for an aptamer selection using the SELEX technology ...
In this study, we developed a systematic evolution of ligands by exponential enrichment (SELEX) meth...
In this study, we developed a systematic evolution of ligands by exponential enrichment (SELEX) meth...
Aptamers are functional nucleic acid (FNA) species capable of specifically binding a target ligand w...
ABSTRACT: To address limitations in the production of DNA aptamers against small molecules, we intro...
Aptamers are synthetic single-stranded DNA or RNA sequences that can fold into tertiary structures a...
Aptamers are short sequences of single-stranded DNA or RNA that are able to specifically bind variou...
ABSTRACT: Aptamers are agents able to bind tightly and selectively to disease markers, offering grea...
Low-Cost diagnostic and screening tools are of vital importance for low resources countries like tho...
Aptamers are becoming a viable alternative to antibodies as bio-recognition elements in analytical, ...
Molecular recognition of disease biomarkers is essential for the detection, monitoring, and treatmen...
We describe an innovative selection approach to generate self-reporting aptamers (SRAs) capable of c...
Aptamers are an emerging class of molecules that are valued for their ability to bind with high affi...
We describe a multiple combined strategy to discover novel aptamers specific for clenbuterol (CBL). ...
We have applied SELEX (Systematic Evolution of Ligands by EXponential enrichment), a combinatorial m...
Small organic molecules are challenging targets for an aptamer selection using the SELEX technology ...
In this study, we developed a systematic evolution of ligands by exponential enrichment (SELEX) meth...
In this study, we developed a systematic evolution of ligands by exponential enrichment (SELEX) meth...
Aptamers are functional nucleic acid (FNA) species capable of specifically binding a target ligand w...
ABSTRACT: To address limitations in the production of DNA aptamers against small molecules, we intro...